Talkspace, Inc.
Universal Health Services, Inc. (UHS) Announces Agreement to Acquire Talkspace (TALK) for $5.25 Per Share
Universal Health Services, Inc. (NYSE:UHS) is among the 11 Most Oversold Stocks to Buy Now. On March 9, 2026, Universal Health Services, Inc. (NYSE:UHS) announced a definitive agreement to acquire Talkspace (TALK) for $5.25 per share, implying an enterprise value of about $835M. The transaction will be financed through borrowings under the company’s existing revolving
Source: Insider Monkey Mar 12, 2026
Can Universal Health's $835M Acquisition of Talkspace Accelerate Growth?
UHS to buy Talkspace for $5.25 per share, aims to expand its digital mental health reach and build a hybrid behavioral care model.
Source: Zacks Mar 10, 2026
Wall Street Analysts Issue New Stock Ratings & Price Targets
Overview of recent analyst rating changes including upgrades for Rivian, CrowdStrike, and Teladoc, and downgrades for Qualcomm and Novo Nordisk, based on demand projections, market positioning, and valuation.
Source: IndexBox Mar 10, 2026
Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
Four names are drawing analyst attention this week, with TD Cowen stepping back from Novo Nordisk A/S (NYSE:NVO), Truist trimming its target on Korn Ferry (NYSE:KFY), Morgan Stanley adjusting expectations for Jefferies Financial Group Inc. (NYSE:JEF), and KeyBanc effectively closing the book on Talkspace Inc. (NASDAQ:TALK) following its acquisition announcement. The moves reflect a mix ... Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
Source: 24/7 Wall St. Mar 10, 2026
Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls
Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls
Source: The Fly Mar 10, 2026
Analyst Rating Changes: Upgrades for GE Vernova, AutoZone, Verizon, Brinker, Iqvia; Downgrades for Starbucks, Talkspace, Western Alliance, Brown-Forman, Marriott Vacations
A summary of recent analyst rating changes across major firms, detailing key upgrades and downgrades with reasons including performance, margins, subscriber growth, and strategic outlooks.
Source: IndexBox Mar 9, 2026
- Blood Pressure Monitors
- Computer Monitors
- Computer Servers
- Computer Software
- Defibrillators
- Desktop Computers
- Digital Thermometers
- External Hard Drives
- File Cabinets
- Graphic Cards
- Keyboards
- Laptops
- Medical Examination Gloves
- Medical Syringes
- Mice
- Monitors
- Motherboards
- Network Routers
- Networking Routers
- Office Chairs
- Office Desks
- Patient Monitoring Equipment
- Print Cartridges
- Printers
- Projectors
- Servers
- Smartphones
- Sterilization Indicators
- Stethoscopes
- Ultrasound Machines
- Blood Glucose Monitors
- Business Strategy Guides
- Cloud Computing Services
- Computer Monitors
- Computer Servers
- Custom Software Development
- Data Analytics Services
- Defibrillators
- Desktop Computers
- Economic Feasibility Studies
- Electrocardiographs
- Environmental Consulting Reports
- Financial Analysis Reports
- Geological Survey Studies
- IT Consulting Services
- IT System Integration
- Laptops
- Managed IT Services
- Management Consulting Reports
- Market Research Reports
- MRI Machines
- Nebulizers
- Network Security Services
- Networking Switches
- Project Management Software
- Software Maintenance Services
- Software Packages
- Solid State Drives
- Stethoscopes
- Surgical Sutures
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.